WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jessica HopfieldDirector2024-05-1345,000$5.64
$253.85kBuy
Gilmore Neil OneillCEO2024-03-0577,824$9.42
$732.87kSell
Baisong MeiSVP CHIEF MEDICAL OFFICER2024-03-0420,327$9.42
$191.42kSell
Bruce EatonEVP CBO AND CTO2023-12-05103$10.90
$1.12kSell
Bruce EatonEVP CBO AND CTO2023-11-14695$8.21
$5.71kSell
Bruce EatonEVP CBO AND CTO2023-11-07139$8.40
$1.17kSell
Bruce EatonEVP CBO AND CTO2023-09-06103$8.82
$908.46Sell
Bruce EatonEVP CBO AND CTO2023-08-11702$8.59
$6.03kSell
Bruce EatonEVP CBO AND CTO2023-08-08141$8.39
$1.18kSell
Baisong MeiSVP CHIEF MEDICAL OFFICER2023-07-194,317$8.80
$37.99kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
State Street Corp10.65%8,760,151$49.23MInstitution
Vanguard Group Inc10.40%8,555,597$48.08MInstitution
Blackrock Inc9.52%7,832,781$44.02MInstitution
Deep Track Capital LP6.72%5,527,290$31.06MInstitution
Third Rock Ventures Iii LP4.75%3,906,176$21.95MInsider
Kevin P. Starr4.75%3,906,176$21.95MInsider
Polaris Venture Management Co Vi LLC4.62%3,797,144$21.34MInsider
Viking Global Investors LP3.64%2,996,590$16.84MInsider
Kevin Bitterman3.40%2,797,144$15.72MInsider
Flagship Ventures Fund Iv LP3.39%2,786,967$15.66MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT67.25%32.75%Net SellingNet Selling
TVTX60.31%39.69%Net SellingNet Selling
NKTX64.47%35.53%Net BuyingNet Buying
VYGR54.30%45.70%Net SellingNet Selling
CBUS15.20%84.80%Net Buying
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 82.53% institutional shareholders, 40.19% Editas Medicine insiders, and 0.00% retail investors. Third Rock Ventures Iii LP is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 4.75% of the company. Third Rock Ventures Iii LP's Editas Medicine shares are currently valued at $21.95M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.